Heartburn drug esomeprazole is first proton pump inhibitor to be sold outside pharmacies in the UK Nexium Control has become the first proton pump inhibitor in the UK to be made available in corner shops and supermarkets, following its reclassification to a general sales list medicine.…
First-in-class oral drug approved for psoriasis conditions in Europe The European Commission has authorised apremilast (Celgene’s Otezla), a first-in-class oral drug for the treatment of chronic plaque psoriasis and psoriatic arthritis in patients who have failed first-line systemic therapies.…
Study questions FDA warning over adverse cognitive effects of statins In 25 placebo-controlled trials involving nearly 47,000 patients, adverse cognitive outcomes attributable to statins were rarely reported, researchers found.…
Drug shortages: it’s time for Europe to act Unlike the United States, Europe has no plan for coordinated action to mitigate drug shortages.…
Drug manufacturers propose alert system to mitigate medicine shortages European drug manufacturers have developed a communications framework which they claim could help prevent medicines shortages or lessen their impact.…
EMA recommends suspending licences for 700 drugs over flawed analyses by GVK BiosciencesThe European Medicines Agency is recommending that the marketing authorisation be suspended for more than 700 generic products tested by GVK Biosciences.…
EMA recommends approval of liraglutide as weight loss drugThe European Medicines Agency is recommending that the prescription-only injectable drug liraglutide (Saxenda) should be granted a marketing authorisation as a weight loss product.…
EU approval of AbbVie’s hepatitis C combination therapies challenges Gilead’s Harvoni A highly effective therapy for patients with hepatitis C is being launched by AbbVie in the EU over the next couple of months in direct competition with another treatment made by Gilead that was approved in 2014 and is now being rolled out. …
Pre-reg pharmacists dissatisfied with their training more likely to have trained in community sector Pharmacist trainees who completed their training in the community sector are more likely to be dissatisfied with the experience, while a higher proportion of dissatisfied students trained in London.…
The public’s trust in pharmacy is a mixed pictureWhen it comes to developing pharmacists’ clinical roles, the engagement of patients and the public may be the sticking point.…